Difference between revisions of "Aldolase A"
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | + | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" {infobox header}}| '''{{PAGENAME}}''' |
| − | |||
| − | |||
| − | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 48: | Line 45: | ||
| | | | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 10:23, 10 March 2015
| Substrate peptide name | Aldolase A |
| Synonyms | Fructose-1,6-bisphosphate aldolase A
Muscle-type aldolase |
| Determination type | In situ |
| Source | Homo sapiens |
| Subcellular localization | Cytosol |
| Swissprot ID | P04075 |
| Reactive glutamines | Not determined yet |
| Reactive lysines | - |
| Substrate sequence | |
| Structure | 4ALD |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:1353685 |
| Notes | |
